PFIZER INC Expense Breakdown
No Expense Breakdown for PFE on this site yet.
- 2026-06-28: Biopharma $3.19B.
- 2025-06-29: Biopharma $3.08B.
Source checked: the stored Expense Breakdown page for PFE.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Biopharma |
|---|
| 2026-06-28 | $3.19B |
|---|
| 2025-06-29 | $3.08B |
|---|
Depreciation, Depletion and Amortization: each quarter (3 month)
| Quarter end | Biopharma |
|---|
| 2026-06-28 | $324.00M |
|---|
| 2025-06-29 | $339.00M |
|---|
Research and Development Expense (Excluding Acquired in Process Cost): each quarter (3 month)
| Quarter end | Biopharma |
|---|
| 2026-06-28 | $2.38B |
|---|
| 2025-06-29 | $2.11B |
|---|
Restructuring Charges: each quarter (3 month)
| Quarter end | Biopharma |
|---|
| 2026-06-28 | $390.00M |
|---|
| 2025-06-29 | -$406.00M |
|---|
Selling, General and Administrative Expense: each quarter (3 month)
| Quarter end | Biopharma |
|---|
| 2026-06-28 | $2.34B |
|---|
| 2025-06-29 | $2.34B |
|---|